Andreas Sing to Germany
This is a "connection" page, showing publications Andreas Sing has written about Germany.
Connection Strength
0.668
-
Rapid establishment of laboratory diagnostics for the novel coronavirus SARS-CoV-2 in Bavaria, Germany, February 2020. Euro Surveill. 2020 03; 25(9).
Score: 0.068
-
Genetic diversity and delineation of Salmonella Agona outbreak strains by next generation sequencing, Bavaria, Germany, 1993 to 2018. Euro Surveill. 2019 May; 24(18).
Score: 0.065
-
Whole genome sequencing suggests transmission of Corynebacterium diphtheriae-caused cutaneous diphtheria in two siblings, Germany, 2018. Euro Surveill. 2019 Jan; 24(2).
Score: 0.063
-
Tox-positive Corynebacterium ulcerans in hedgehogs, Germany. Emerg Microbes Infect. 2019; 8(1):211-217.
Score: 0.063
-
Geographically Diverse Clusters of Nontoxigenic Corynebacterium diphtheriae Infection, Germany, 2016-2017. Emerg Infect Dis. 2018 07; 24(7):1239-1245.
Score: 0.061
-
Screening for infectious diseases among newly arrived asylum seekers, Bavaria, Germany, 2015. Euro Surveill. 2018 03; 23(10).
Score: 0.060
-
Whole genome sequencing identifies influenza A H3N2 transmission and offers superior resolution to classical typing methods. Infection. 2018 Feb; 46(1):69-76.
Score: 0.058
-
Corynebacterium species nasopharyngeal carriage in asymptomatic individuals aged = 65 years in Germany. Infection. 2017 Oct; 45(5):607-611.
Score: 0.056
-
Prolonged SARS-CoV-2 RNA Shedding from Therapy Cat after Cluster Outbreak in Retirement Home. Emerg Infect Dis. 2021 07; 27(7):1974-1976.
Score: 0.019
-
Vaccine breakthrough infection and onward transmission of SARS-CoV-2 Beta (B.1.351) variant, Bavaria, Germany, February to March 2021. Euro Surveill. 2021 07; 26(30).
Score: 0.019
-
Detection and viral RNA shedding of SARS-CoV-2 in respiratory specimens relative to symptom onset among COVID-19 patients in Bavaria, Germany. Epidemiol Infect. 2021 06 23; 149:e150.
Score: 0.019
-
Weekly SARS-CoV-2 Sentinel Surveillance in Primary Schools, Kindergartens, and Nurseries, Germany, June-November 2020. Emerg Infect Dis. 2021 08; 27(8):2192-2196.
Score: 0.019
-
Virological COVID-19 surveillance in Bavaria, Germany suggests no SARS-CoV-2 spread prior to the first German case in January 2020. Infection. 2021 Oct; 49(5):1029-1032.
Score: 0.019
-
Detection of the new SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in five SARS-CoV-2 rapid antigen tests (RATs), Germany, March 2021. Euro Surveill. 2021 04; 26(16).
Score: 0.018
-
Epidemiology and transmission characteristics of early COVID-19 cases, 20 January-19 March 2020, in Bavaria, Germany. Epidemiol Infect. 2021 03 02; 149:e65.
Score: 0.018
-
Multicentre comparison of quantitative PCR-based assays to detect SARS-CoV-2, Germany, March 2020. Euro Surveill. 2020 06; 25(24).
Score: 0.017
-
Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series. Lancet Infect Dis. 2020 08; 20(8):920-928.
Score: 0.017
-
[Infections with pneumococci, menigococci, H. influenzae and diphtheria in Germany: the RKI Reference Network for Invasive Bacterial Infections (IBI) at the 5th Würzburg Workshop on Epidemiology, Prevention and Therapy for Invasive Meningococcal Diseases 2010 (meeting report)]. Gesundheitswesen. 2012 Nov; 74(11):747-53.
Score: 0.010